|Bid||0.00 x 30000|
|Ask||0.00 x 30000|
|Day's Range||102.00 - 105.00|
|52 Week Range||59.50 - 136.00|
|Beta (5Y Monthly)||1.13|
|PE Ratio (TTM)||15.70|
|Forward Dividend & Yield||0.23 (0.23%)|
|Ex-Dividend Date||Apr 15, 2021|
|1y Target Est||N/A|
PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Rating Action: Moody's assigns Baa3 rating to PerkinElmer's notes offeringGlobal Credit Research - 04 Mar 2021New York, March 04, 2021 -- Moody's Investors Service, ("Moody's") assigned a Baa3 rating to the proposed offering of senior unsecured 10- and 30-year notes of PerkinElmer, Inc. ("PerkinElmer"). There are no changes to Moody's existing ratings of PerkinElmer including the Baa3 senior unsecured long-term rating. The acquisition slightly increases PerkinElmer's financial leverage to close to 3.0x, up from 2.5x in the last twelve months to September 30, 2020.
Zimmer Biomet (ZBH) states that continued pressure from the COVID-19 pandemic slowed the recovery of elective procedures in the fourth quarter.